Search
Edrophonium Action Pathway (new)
smpdb.ca/view/SMP0126690Drug actionEdrophonium is a cholinesterase inhibitor used in the treatment of myasthenia gravis, that works to prolong the duration of action of acetylcholine. The drug acts rapidly by binding to acetylcholinesterase and cholinesterase halting the ...
Enzymes: High affinity choline transporter 1Distigmine Action Pathway
smpdb.ca/view/SMP0126700Drug actionDistigmine is a cholinesterase inhibitor, a parasympathomimetic agent used in the treatment of neurogenic bladder dysfunction and or myasthenia gravis. This is an experimental drug that acts by inhibiting cholinesterase and also binds di...
Enzymes: High affinity choline transporter 1Carbaryl Action Pathway
smpdb.ca/view/SMP0126728Drug actionCarbaryl is an insecticide in addition to a cholinesterase inhibitor it is used as a treatment to remove head lice. It acts on insects and due to its relative dosage compared to a human, the lice having their acetylcholinesterase inhibit...
Enzymes: High affinity choline transporter 1Methylphosphinic Acid Action Pathway
smpdb.ca/view/SMP0126733Drug actionMethylphosphinic acid is an experimental drug being tested to be a possible cholinesterase inhibitor, as it appears to inhibit the breakdown of acetylcholine. Further research needs to be conducted in order to confirm results, safety and...
Enzymes: High affinity choline transporter 1Somapacitan
go.drugbank.com/drugs/DB15093ApprovedInvestigational[A219126,L15661] This human growth hormone analog differs by the creation of an albumin binding site, and prolonging the effect so that it requires weekly dosing rather than daily.
Butoconazole
go.drugbank.com/drugs/DB00639ApprovedButoconazole is an imidazole antifungal used in gynecology.
Azilsartan medoxomil
go.drugbank.com/drugs/DB08822ApprovedInvestigationalAzilsartan medoxomil is a relatively recently-developed antihypertensive drug that was first approved by the FDA in February 2011. … As hypertension is a major risk factor for cardiovascular disease,[A7354] early management of hypertension has several implications on patients' survival rate and quality of life in the future.
Plicamycin
go.drugbank.com/drugs/DB06810ApprovedWithdrawnPlicamycin is an antineoplastic antibiotic produced by Streptomyces plicatus.
Enoxaparin
go.drugbank.com/drugs/DB01225ApprovedInvestigationalInitially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies.
Bardoxolone
go.drugbank.com/drugs/DB12651InvestigationalIt is a synthetic triterpenoid and a highly potent activator of redox-sensitive signaling pathways that induce programmed cell death (apoptosis) in cancer cells that are under high levels of intrinsic